No ‘Surprise’ Facility Fees For Sanitizer Makers After Responding To COVID-19 Emergency In US

HHS says FDA made subject to monograph program facility fees businesses that began making hand sanitizers in response to temporary guidance easing manufacturing standards "about the same time” the department withdrew the user fee schedule.

More from Regulation

More from Policy & Regulation